pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Preclinical
    SPID-961
    Childhood Epilepsy Shackelford Pharma Inc
  • Preclinical
    SPL-23
    Cystic Fibrosis SpliSense Ltd
  • Phase 2
    SPL-84
    Cystic Fibrosis SpliSense Ltd
  • Phase 2
← prev
page 158 of 271
next →
Pain89
Neurology1
SPN-821
Major Depressive Disorder
$SUPN SUPERNUS PHARMACEUTICALS, INC.
  • Preclinical
    SPU-16
    Multiple Sclerosis$SILO Silo Pharma, Inc.
  • Phase 2
    SPVN-06
    Retinitis Pigmentosa (Retinitis) SparingVision SAS
  • Phase 1
    SPX-303
    Solid Tumor$SHGI Sparx Holdings Group, Inc.
  • Preclinical
    SPX-306
    Unspecified Cancer$SHGI Sparx Holdings Group, Inc.
  • Preclinical
    SPX-308
    Unspecified Cancer$SHGI Sparx Holdings Group, Inc.
  • Preclinical
    SPX-602
    Unspecified Cancer$SHGI Sparx Holdings Group, Inc.
  • Preclinical
    SPX-608
    Unspecified Cancer$SHGI Sparx Holdings Group, Inc.
  • Preclinical
    SPX-629
    Unspecified Cancer$SHGI Sparx Holdings Group, Inc.
  • Preclinical
    SPY-DYS45-55
    Duchenne Muscular Dystrophy MyoGene Bio LLC
  • Phase 1
    SR-604
    Hemophilia A (Factor VIII Deficiency) Equilibra Bioscience LLC
  • Phase 2
    SR-750
    Trigeminal Neuralgia (Tic Douloureux) Shanghai SIMR Biotech Co Ltd
  • Preclinical
    SRC-3KO Treg Adoptive Cell Therapy
    Glioblastoma Multiforme (GBM) CoRegen Inc
  • Preclinical
    SRC-3KO Treg Allogeneic Cell Therapy
    Solid Tumor CoRegen Inc
  • Phase 2
    SRD-002
    Diastolic Heart Failure (HFpEF) Sardocor Corp
  • Phase 2
    SRD-003
    Duchenne Muscular Dystrophy Sardocor Corp
  • Phase 1
    SRK-439
    Obesity$SRRK Scholar Rock Holding Corp
  • Phase 1
    SRP-3D
    Neuropathic Pain (Neuralgia) South Rampart Pharma LLC
  • Phase 2
    SRT-100
    Genital Warts (Condylomata Acuminata) G&E Herbal Biotechnology Co., Ltd.
  • Phase 2
    SRX-246
    Huntington Disease Azevan Pharmaceuticals Inc
  • Preclinical
    SRX-25
    esketamine
    Treatment Resistant Depression Nexalis Therapeutics Ltd
  • Phase 2
    ST-002
    Cushing's Syndrome SteroTherapeutics LLC
  • Preclinical
    ST-003
    Primary Sclerosing Cholangitis SteroTherapeutics LLC
  • Phase 1
    ST-01156
    Bile Duct Cancer (Cholangiocarcinoma) Seed Therapeutics Inc
  • Phase 2
    ST-266
    Necrotizing Enterocolitis Noveome Biotherapeutics Inc
  • Phase 2
    ST-503
    Neuropathic Pain (Neuralgia)$SGMO SANGAMO THERAPEUTICS, INC
  • Preclinical
    ST-7
    Radiation Toxicity (Radiation Sickness, Acute Radiation S… Phoenicia Biosciences Inc